期刊文献+

重复献血者与初次献血者携带肝炎病毒可能性的比较 被引量:3

The Comparative Analysis on the Possibility of Carrying Hepatitis Virus between Repeat Donors and First-time Donors
下载PDF
导出
摘要 目的分析重复献血者与初次献血者携带肝炎病毒的可能性。方法以2002~2005年及2007~2010年间献血者资料为例,将献血者分为重复献血者和初次献血者,分析两类献血者的构成、献血间隔、血液筛查结果等资料,并对部分HBsAg和抗-HCV筛查结果进行确证。结果重复献血者捐献的血液占全部献血的比例由2002~2005年度的25.2%,上升到2007~2010年度的29.9%,平均年龄由38岁降至32岁;重复献血者捐献的血液HBsAg和抗-HCV不合格率明显低于初次献血者,且不合格样本的阳性确证率也明显低于初次献血者。结论重复献血者携带肝炎病毒的可能性较初次献血者低,是较安全的献血人群,应巩固和发展固定的无偿献血者队伍,保障血液安全。 Objective To compare and analyze the possibility of carrying hepatitis virus between repeat donors and first-time donors. Methods The data from routine blood collection and screening during 2002 to 2005 and 2007 to 2010 were used. The donations were divided into repeat donations and first-time donations according to the donation time of the donors, and the donation interval of repeat donors were analyzed. The blood screening data were also analyzed and some of the reactive results of HBsAg and anti-HCV were confirmed. Results The composition rate of repeat donations was in- creased from 25.2% in 2002~2005 to 29.9~ in 2007~2010. The average age of repeat donors was decreased from 38 to 32 years old. The reactive rate of HBsAg and anti-HCV of repeat donations was significantly lower than that of the first- time donations. And the confirmation rate of reactive donations from repeat donors was also lower than that from the first- time donors. Conclusion The viral carrying possibility of repeat donors is lower than that of the first-time donors. Repeat donors are the safety donors and the non-remunerate voluntary blood donors should be emphasized and developed in order to improve the blood safety.
出处 《临床输血与检验》 CAS 2013年第3期193-195,共3页 Journal of Clinical Transfusion and Laboratory Medicine
基金 上海市自然科学基金(No.10ZR1428400) 奉贤区科学技术发展基金(No.奉科2005-35)资助
关键词 血液安全 重复献血者 肝炎病毒 Blood safety Repeat donor Hepatitis virus
  • 相关文献

参考文献9

  • 1Holland PV. Post-transfusion hepatitis: current risks and causes[J]. Vox Sang, 1998, 74 (Suppl 2): 185- 141. 被引量:1
  • 2Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and esti- mated window-period risk in the American Red Cross blood donor population[J]. Transfusion, 2002,42 (8) : 975-979. 被引量:1
  • 3Soldan K, Barbara JAJ, Ramsay ME,et al. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations en- tering the blood supply in England, 1993-2001[J]. Vox Sang, 2003,84 (4) : 274-286. 被引量:1
  • 4Zou S, Dorsey KA, Notari EP,et al. Prevalence, inci- dence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing[J]. Transfusion, 2010,50 (7) : 1495-1504. 被引量:1
  • 5Lackritz EM, Satten GA, Aberle-Grasse J,et al. Esti mated risk of transmission of the human immunodefi ciency virus by screened blood in the United States[J]. N Engl J Med,1995,333(26):1721-1725. 被引量:1
  • 6王迅,贾尧,谢云峥,励修楣,刘晓颖,伍晓菲.联合运用数学模型对输血传播丙型肝炎病毒残留风险评估的分析[J].中华流行病学杂志,2011,32(9):936-939. 被引量:11
  • 7刘宇宁,王迅,贾尧,伍晓菲,蔡菊英,刘晓音,苏志华.上海奉贤地区重复献血者血液传播HBV的残留风险[J].中国输血杂志,2012,25(1):50-52. 被引量:4
  • 8Zou S,Musavi F,Notari EP,et al. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006[J]. Transfusion,2008,48 (12) :2531-2539. 被引量:1
  • 9张雄民,孟妍,台慧玲,孙大圣,李超,王迅.上海地区无偿献血招募过程中延缓献血原因的分析[J].中国输血杂志,2012,25(11):1194-1196. 被引量:11

二级参考文献38

  • 1庄辉.乙型肝炎流行病学研究进展[J].国外医学(流行病学.传染病学分册),2004,31(3):133-135. 被引量:149
  • 2王迅.核酸检测技术(NAT)及其在血液筛检中的应用[J].中国输血杂志,2004,17(6):465-468. 被引量:30
  • 3Holland PV. Post-transfusion hepatitis: current risks and causes. Vox Sang, 1998,74 Suppl 2:S135-141. 被引量:1
  • 4Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion, 2002,42(8) :975-979. 被引量:1
  • 5Soldan K, Barbara JAJ, Ramsay ME, et al. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang, 2003,84 (4) : 274-286. 被引量:1
  • 6Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immtmodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion, 2010, 50 (7) : 1495-1504. 被引量:1
  • 7Gallarda JL, Dragon E. Blood screening by nucleic acid amplification technology : current issues, future challenges. Mol Diag, 2000, 5 (1):11-22. 被引量:1
  • 8Seed CR, Cheng A, Ismay SL, et al. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT. Transfusion, 2002,42 (10) : 1365-1372. 被引量:1
  • 9AuBuchon JP, Birkmeyer JD, Busch ME Safety of the blood supply in the United States: opportunities and controversies. Ann Intern Med, 1997, 127(10) : 904-909. 被引量:1
  • 10Zou S, Fang CT, Dodd RY. On residual risk assessment for first- time donations. Transfusion ,2007,47(12) :2348-2349. 被引量:1

共引文献20

同被引文献20

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部